Glaukos CDO sells 716 shares in pre-set trade
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glaukos Corp chief development officer Tomas Navratil reported a small open-market sale of company stock. On July 1, he sold 716 shares of Glaukos common stock at an average price of $139.06 per share in an open-market transaction.
After the sale, Navratil directly holds 87,634 shares of Glaukos common stock, so the transaction represents a minor portion of his overall stake. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026, indicating it was scheduled in advance. His holdings also include 38,817 restricted stock units that have not yet vested or been delivered.
Insights
Routine, pre-planned insider sale of a small share block.
The chief development officer of Glaukos Corp, Tomas Navratil, executed an open-market sale of 716 common shares at $139.06 per share. Following this transaction, he still directly owns 87,634 shares, plus unvested restricted stock units.
The filing notes the trade was made under a Rule 10b5-1 trading plan adopted on March 12, 2026. Such plans pre-schedule trades, reducing the informational value of timing. The sale size is small relative to his stake, suggesting a routine liquidity event rather than a major position change.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 716 | $139.06 | $100K |
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
- F2. Includes 38,817 restricted stock units that have not yet vested or been delivered to the Reporting Person.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units financial
open-market sale financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Is the GKOS insider transaction characterized as a buy or sell activity?
AI-generated analysis. How Rhea-AI works. Not financial advice.